A Study Comparing ARB With Radium-223 vs ARB Therapy With Placebo and the Effect Upon Survival for mCRPC Patients (ESCALATE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04237584

Recruitment Status : Terminated (The study was stopped due to insurmountable enrollment challenges affecting trial accrual, resulting from the rapidly evolving treatment options for advanced prostate cancer.)

First Posted : January 23, 2020

Last Update Posted : April 8, 2022

Sponsor:

Collaborators:

Bayer

Carolina Urologic Research Center

Tulane University

Barbara Ann Karmanos Cancer Institute

Information provided by (Responsible Party):

MANA RBM

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	March 7, 2022
Actual Study Completion Date :	March 7, 2022

To Top